Digital Europe – Testing and Experimentation Facility for Health – 2022

Digital Europe - Testing and Experimentation Facility for Health - 2022 Funds for: fostering trust and acceptance by the user community and boost the roll-out of European AI, data and robotics solutions from the lab to the market, through its validation process, increasing the maturity of the tested solutions.

2022-05-17

30 million euro

Additional information

Additional regional information :

Associated countries and countries which are in ongoing negotiations for an association agreement and where the agreement enters into force before grant signature are equally eligible to the grant

For more information: Click here

Amount :

To view this information , thank you for logging in.

Useful :

To view this information , thank you for logging in.

Sectors : Cooperation & Development Education & Training Health

Beneficiary : All beneficiaries Association & NGO

Regions : Developing countries, European Economic Area, European Union

Category : Call for proposals

Manager : European Commission

Contact :

To view this information , thank you for logging in.

Advice :

, thank you for logging in.

Priorities and funded actions

Objectives

To foster trust and acceptance by the user community and boost the roll-out of European AI, data and robotics solutions from the lab to the market, through its validation process, increasing the maturity of the tested solutions
To accelerate testing by creating common, accessible infrastructures and services, which combine the necessary technical, administrative, medical and ethical procedures and certifications, as appropriate
To increase the effectiveness, resilience and sustainability of European health and care systems and reduce healthcare delivery inequalities in Europe, while ensuring compliance with relevant legal, ethical, quality and interoperability standards and requirements

Priorities

Priority 1: to build synergies with existing and future European initiatives related to the Digital Transformation of Health and Care, the European Health Data Space, AI Regulation, Data Governance Act, Europe’s Beating Cancer Plan
Priority 2: To allow for large-scale in-silico, in vitro, ex-vivo and in vivo testing, when relevant

Among financed actions

Prevention, diagnostics, treatments and rehabilitation of infectious and non-communicable diseases, including cancer, dementia, paediatrics and promotion of healthy lifestyles
Monitoring the progress of long‑term conditions in function of treatment (e.g.diabetes mellitus, neurodegenerative diseases etc.)
Support to doctors’ decision-making, including personalised, predictive and age- and gender-sensitive treatments
Detection of tumours from imaging

Additional information